HealthEquity (NASDAQ:HQY) Issues FY25 Earnings Guidance

HealthEquity (NASDAQ:HQY) issued an update on its FY25 earnings guidance on Tuesday morning. The company provided EPS guidance of $2.79-2.96 for the period, compared to the consensus EPS estimate of $2.86. The company issued revenue guidance of $1.14-1.16 billion, compared to the consensus revenue estimate of $1.15 billion.

HealthEquity Price Performance

NASDAQ HQY traded up $0.57 during mid-day trading on Tuesday, hitting $83.53. The stock had a trading volume of 734,140 shares, compared to its average volume of 598,828. The firm’s 50 day moving average is $78.54 and its 200 day moving average is $72.66. HealthEquity has a twelve month low of $48.86 and a twelve month high of $84.13. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.93 and a quick ratio of 4.93. The stock has a market capitalization of $7.17 billion, a price-to-earnings ratio of 244.00, a PEG ratio of 1.28 and a beta of 0.53.

Analyst Upgrades and Downgrades

HQY has been the subject of several recent research reports. Barclays increased their price objective on HealthEquity from $84.00 to $104.00 and gave the company an overweight rating in a research note on Friday, February 23rd. Wells Fargo & Company raised their target price on HealthEquity from $89.00 to $93.00 and gave the stock an overweight rating in a research note on Wednesday, December 6th. Raymond James raised their target price on HealthEquity from $90.00 to $95.00 and gave the stock an outperform rating in a research note on Wednesday, December 13th. Barrington Research reaffirmed an outperform rating and issued a $85.00 target price on shares of HealthEquity in a research note on Monday, December 4th. Finally, JPMorgan Chase & Co. cut their target price on HealthEquity from $81.00 to $73.00 and set an overweight rating for the company in a research note on Friday, December 1st. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of Moderate Buy and an average target price of $87.38.

Insider Activity at HealthEquity

In related news, EVP Delano Ladd sold 2,586 shares of the firm’s stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $70.00, for a total transaction of $181,020.00. Following the completion of the transaction, the executive vice president now directly owns 52,495 shares in the company, valued at approximately $3,674,650. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold 7,643 shares of company stock worth $592,205 in the last three months. 2.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On HealthEquity

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Lazard Asset Management LLC boosted its stake in shares of HealthEquity by 117.9% in the 3rd quarter. Lazard Asset Management LLC now owns 549 shares of the company’s stock valued at $40,000 after buying an additional 297 shares during the period. Castleview Partners LLC purchased a new position in shares of HealthEquity in the 2nd quarter valued at about $39,000. Coppell Advisory Solutions LLC purchased a new position in shares of HealthEquity in the 2nd quarter valued at about $48,000. Belpointe Asset Management LLC raised its position in shares of HealthEquity by 229.0% during the 1st quarter. Belpointe Asset Management LLC now owns 1,066 shares of the company’s stock worth $63,000 after acquiring an additional 742 shares in the last quarter. Finally, Captrust Financial Advisors raised its position in shares of HealthEquity by 92.5% during the 1st quarter. Captrust Financial Advisors now owns 1,176 shares of the company’s stock worth $79,000 after acquiring an additional 565 shares in the last quarter. Hedge funds and other institutional investors own 98.46% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.